Format

Send to

Choose Destination
Kidney Int. 2016 Jun;89(6):1178-9. doi: 10.1016/j.kint.2016.03.012.

ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials.

Author information

1
Department of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: christina.wyatt@mssm.edu.
2
ISCHEMIA Clinical Coordinating Center, New York University School of Medicine, New York, New York, USA.
3
Department of Medicine, Division of Nephrology, Stanford School of Medicine, Stanford, California, USA.
4
Department of Medicine, Division of Cardiology, New York University School of Medicine, New York, New York, USA.

Abstract

Despite the high cardiovascular risk associated with chronic kidney disease, a recent systematic review confirmed that patients with kidney disease remain underrepresented in cardiovascular trials. Two ongoing trials are assessing the risk:benefit of aggressive evaluation and intervention for ischemic heart disease in patients with advanced chronic kidney disease.

PMID:
27181770
DOI:
10.1016/j.kint.2016.03.012
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center